| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1701-2163(16)35242-2 |
| P698 | PubMed publication ID | 22555138 |
| P2093 | author name string | Lawrence Paszat | |
| Michael Fung Kee Fung | |||
| Michael Shier | |||
| Joan Murphy | |||
| Sheila Dunn | |||
| Erin B Kennedy | |||
| C Meg McLachlin | |||
| Danusia Gzik | |||
| Ontario Cervical Screening Program | |||
| Program in Evidence-based Care | |||
| P2860 | cites work | Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis | Q33233738 |
| Ontario cervical cancer screening clinical practice guidelines | Q33283472 | ||
| Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data | Q33488158 | ||
| Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence | Q34176414 | ||
| HPV testing in primary cervical screening: a systematic review and meta-analysis | Q34255310 | ||
| Human papillomavirus and Papanicolaou tests to screen for cervical cancer | Q34702284 | ||
| HPV screening for cervical cancer in rural India | Q34973414 | ||
| Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme | Q35324720 | ||
| Human papillomavirus infection in adolescents: a rational approach | Q35996669 | ||
| Cervical cytology testing in teens | Q36248736 | ||
| Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study | Q37135912 | ||
| Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study | Q37281729 | ||
| Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries | Q37291430 | ||
| The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation | Q40585040 | ||
| Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. | Q44320222 | ||
| Screening for cervical cancer: will women accept less? | Q50756274 | ||
| HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. | Q51824401 | ||
| Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. | Q53028990 | ||
| Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. | Q53304855 | ||
| AGREE II: Advancing guideline development, reporting, and evaluation in health care | Q56637210 | ||
| The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy | Q80225343 | ||
| Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 | ||
| Correlates of intent to seek unnecessary pap tests among elderly women | Q81441063 | ||
| Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial | Q82586477 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 453-458 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | Journal of Obstetrics and Gynaecology Canada | Q15761143 |
| P1476 | title | Cervical screening: a guideline for clinical practice in Ontario | |
| P478 | volume | 34 |
| Q28077487 | Aborder les soins préventifs chez les aînés |
| Q28069648 | Approach to preventive care in the elderly |
| Q44001850 | Are there flaws in the follow-up of women with low-grade cervical dysplasia in Ontario? |
| Q41057743 | Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing |
| Q53970298 | Barriers to Cervical Screening Among Sex Workers in Vancouver. |
| Q53839947 | Changes on the horizon for cervical cancer screening. |
| Q34508821 | Colposcopic management of abnormal cervical cytology and histology |
| Q37355899 | Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology |
| Q37482249 | Comparing stage of diagnosis of cervical cancer at presentation in immigrant women and long-term residents of Ontario: a retrospective cohort study |
| Q35943659 | Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval |
| Q46672314 | Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods. |
| Q35889801 | Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians |
| Q39379963 | Exploring colposcopists' attitudes towards use of HPV testing as a primary screening tool for cervical cancer in British Columbia |
| Q39431966 | Financial Incentives and Cervical Cancer Screening Participation in Ontario's Primary Care Practice Models |
| Q37735908 | Frequency of and variation in low-value care in primary care: a retrospective cohort study |
| Q39477130 | Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial |
| Q55077396 | Implementation considerations using HPV self-collection to reach women under-screened for cervical cancer in high-income settings. |
| Q86306579 | Management of abnormal cervical cytology screening in adolescent and young women in a canadian colposcopy centre: a descriptive analysis |
| Q92993905 | Measurement without management: qualitative evaluation of a voluntary audit & feedback intervention for primary care teams |
| Q36166318 | Missed connections: Unintended consequences of updated cervical cancer screening guidelines on screening rates for sexually transmitted infections |
| Q39051912 | Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD. |
| Q90243524 | Psychiatric morbidity and cervical cancer screening: a retrospective population-based case-cohort study |
| Q33625941 | Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial |
| Q57571491 | Rethinking cervical cancer screening |
| Q43924111 | Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline |
| Q36441291 | Small-area variation in screening for cancer, glucose and cholesterol in Ontario: a cross-sectional study |
| Q35876962 | The Korean guideline for cervical cancer screening |
| Q37719631 | The road ahead for cervical cancer prevention and control |
| Q35889806 | Women's intentions to receive cervical cancer screening with primary human papillomavirus testing |
| Q42251001 | cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens |
Search more.